FOS and nonpapillary renal cell carcinoma: Pharmacological inhibition of c-Fos/AP-1 using T-5224 reduced migration of ccRCC cell lines but did not affect cell proliferation (Fig. 3f and Supplementary Fig. 4b–d)27,28.